EE9900211A - Substituted pyrazole derivatives - Google Patents

Substituted pyrazole derivatives

Info

Publication number: EE9900211A
Authority: EE; Estonia
Prior art keywords: pyrazole derivatives; substituted pyrazole; substituted; derivatives; pyrazole
Prior art date: 1996-11-26

Application number

EEP199900211A

Other languages

Estonian (et)

Inventor

Straub Alexander

F�rstner Chantal

Jaetsch Thomas

Feurer Achim

Kast Raimund

Stasch Johannes-Peter

Perzborn Elisabeth

H�tter Joachim

Dembowsky Klaus

Original Assignee

Bayer Aktiengesellschaft

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-11-26

Filing date

1997-11-14

Publication date

1999-12-15

1997-11-14 Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft

1999-12-15 Publication of EE9900211A publication Critical patent/EE9900211A/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Vascular Medicine (AREA)
Diabetes (AREA)
Hematology (AREA)
Hospice & Palliative Care (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

EEP199900211A 1996-11-26 1997-11-14 Substituted pyrazole derivatives EE9900211A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19649460A DE19649460A1 (en)	1996-11-26	1996-11-26	New substituted pyrazole derivatives
PCT/EP1997/006366 WO1998023619A1 (en)	1996-11-26	1997-11-14	Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases

Publications (1)

Publication Number	Publication Date
EE9900211A true EE9900211A (en)	1999-12-15

Family

ID=7813100

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP199900211A EE9900211A (en)	1996-11-26	1997-11-14	Substituted pyrazole derivatives

Country Status (25)

Country	Link
EP (1)	EP0944631B1 (en)
JP (2)	JP4422800B2 (en)
CN (1)	CN1122032C (en)
AR (1)	AR010310A1 (en)
AT (1)	ATE259812T1 (en)
AU (1)	AU729642B2 (en)
BR (1)	BR9714363A (en)
CA (1)	CA2272584C (en)
CZ (1)	CZ185099A3 (en)
DE (2)	DE19649460A1 (en)
DK (1)	DK0944631T3 (en)
EE (1)	EE9900211A (en)
ES (1)	ES2214646T3 (en)
HU (1)	HUP0000562A3 (en)
ID (1)	ID21881A (en)
IL (1)	IL129998A0 (en)
MX (1)	MXPA99004826A (en)
NO (1)	NO992400D0 (en)
NZ (1)	NZ335890A (en)
PT (1)	PT944631E (en)
SK (1)	SK67699A3 (en)
TR (1)	TR199901172T2 (en)
TW (1)	TW403746B (en)
WO (1)	WO1998023619A1 (en)
ZA (1)	ZA9710573B (en)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19744026A1 (en) *	1997-10-06	1999-04-08	Hoechst Marion Roussel De Gmbh	Pyrazole derivatives, their preparation and their use in medicinal products
DE19827679A1 (en) *	1998-06-22	1999-12-23	Dresden Arzneimittel	New pyrazolo(3,4-d)pyrimidine derivative adenosine A3 receptor antagonists, used for treating epilepsy, asthma or allergy
DE19834045A1 (en) *	1998-07-29	2000-02-03	Bayer Ag	(4-Amino-5-ethylpyrimidin-2-yl) -1- (2-fluorobenzyl) -1H-pyrazolo [3,4-b] pyridine
DE19834044A1 (en) *	1998-07-29	2000-02-03	Bayer Ag	New substituted pyrazole derivatives
DE19834047A1 (en)	1998-07-29	2000-02-03	Bayer Ag	Substituted pyrazole derivatives
GB9824310D0 (en) *	1998-11-05	1998-12-30	Univ London	Activators of soluble guanylate cyclase
DE19920352A1 (en) *	1999-05-04	2000-11-09	Bayer Ag	Substituted pyrazole derivative
DE19943635A1 (en)	1999-09-13	2001-03-15	Bayer Ag	Novel aminodicarboxylic acid derivatives with pharmaceutical properties
DE19943636A1 (en)	1999-09-13	2001-03-15	Bayer Ag	Novel dicarboxylic acid derivatives with pharmaceutical properties
DE19943634A1 (en)	1999-09-13	2001-04-12	Bayer Ag	Novel dicarboxylic acid derivatives with pharmaceutical properties
DE10021069A1 (en) *	2000-04-28	2001-10-31	Bayer Ag	Substituted pyrazole derivative
DE10057754A1 (en)	2000-11-22	2002-05-23	Bayer Ag	New cyclic sulfonamido-substituted pyrazolo (3,4-b) pyridine derivatives, are soluble guanylate cyclase stimulants useful e.g. for treating cardiovascular or central nervous system diseases, sexual dysfunction or inflammation
DE10057751A1 (en)	2000-11-22	2002-05-23	Bayer Ag	New carbamate-substituted pyrazolo (3,4-b) pyridine derivatives, are soluble guanylate cyclase stimulants useful e.g. for treating cardiovascular or central nervous system diseases, sexual dysfunction or inflammation
WO2002042299A1 (en)	2000-11-22	2002-05-30	Bayer Aktiengesellschaft	Novel lactame-substituted pyrazolopyridine derivatives
AR031176A1 (en)	2000-11-22	2003-09-10	Bayer Ag	NEW DERIVATIVES OF PIRAZOLPIRIDINA SUBSTITUTED WITH PIRIDINE
DE10109858A1 (en)	2001-03-01	2002-09-05	Bayer Ag	Novel halogen-substituted aminodicarboxylic acid derivatives
DE10109861A1 (en)	2001-03-01	2002-09-05	Bayer Ag	Novel side chain halogenated aminodicarboxylic acid derivatives
DE10110749A1 (en) *	2001-03-07	2002-09-12	Bayer Ag	Substituted aminodicarboxylic acid derivatives
DE10122894A1 (en)	2001-05-11	2002-11-14	Bayer Ag	New pyrazolo(3,4-b)pyridin-3-yl)-5-pyrimidinyl sulfonates, are soluble guanyl cyclase stimulants useful e.g. for treating cardiovascular, thromboembolic or central nervous system diseases
DE10132416A1 (en) *	2001-07-04	2003-01-16	Bayer Ag	New morpholine-bridged pyrazolopyridine derivatives
DE10220570A1 (en)	2002-05-08	2003-11-20	Bayer Ag	Carbamate-substituted pyrazolopyridines
DE10232572A1 (en) *	2002-07-18	2004-02-05	Bayer Ag	New 2,5-disubstituted pyrimidine derivatives
DE10244810A1 (en) *	2002-09-26	2004-04-08	Bayer Ag	New morpholine-bridged indazole derivatives
CA2530679A1 (en) *	2003-06-30	2005-04-07	Hif Bio, Inc.	Compounds for treating angiogenesis
DE102005050376A1 (en)	2005-10-21	2007-05-31	Bayer Healthcare Ag	Dicarboxylic acid derivatives and their use
DE102005050375A1 (en)	2005-10-21	2007-04-26	Bayer Healthcare Ag	Tetrazole derivatives and their use
DE102005050497A1 (en)	2005-10-21	2007-04-26	Bayer Healthcare Ag	Difluorophenol derivatives and their use
DE102005050498A1 (en)	2005-10-21	2007-06-06	Bayer Healthcare Aktiengesellschaft	Cyclopropylacetic acid derivatives and their use
DE102005050377A1 (en)	2005-10-21	2007-04-26	Bayer Healthcare Ag	Heterocyclic compounds and their use
DE102006020327A1 (en) *	2006-04-27	2007-12-27	Bayer Healthcare Ag	Heterocyclic substituted, fused pyrazole derivatives and their use
DE102006043443A1 (en)	2006-09-15	2008-03-27	Bayer Healthcare Ag	Novel aza-bicyclic compounds and their use
DE102007015034A1 (en)	2007-03-29	2008-10-02	Bayer Healthcare Ag	Lactam-substituted dicarboxylic acids and their use
DE102007015035A1 (en)	2007-03-29	2008-10-02	Bayer Healthcare Ag	Substituted dibenzoic acid derivatives and their use
DE102007026392A1 (en)	2007-06-06	2008-12-11	Bayer Healthcare Ag	Solutions for the perfusion and preservation of organs and tissues
DE102007028406A1 (en)	2007-06-20	2008-12-24	Bayer Healthcare Ag	Substituted oxazolidinones and their use
DE102007028320A1 (en)	2007-06-20	2008-12-24	Bayer Healthcare Ag	Substituted oxazolidinones and their use
DE102007028407A1 (en)	2007-06-20	2008-12-24	Bayer Healthcare Ag	Substituted oxazolidinones and their use
DE102007028319A1 (en)	2007-06-20	2008-12-24	Bayer Healthcare Ag	Substituted oxazolidinones and their use
CN105622580B (en)	2008-04-28	2019-06-21	詹森药业有限公司	Benzimidazole as prolyl hydroxylase inhibitors
EP2138178A1 (en)	2008-06-28	2009-12-30	Bayer Schering Pharma Aktiengesellschaft	Oxazolidninones for the treatment fo chronic obstructive pulmonary disease (COPD) and/or asthma
DE102008063992A1 (en)	2008-12-19	2010-09-02	Lerner, Zinoviy, Dipl.-Ing.	New aliphatic substituted pyrazolopyridines and their use
DE102009004245A1 (en)	2009-01-09	2010-07-15	Bayer Schering Pharma Aktiengesellschaft	Novel fused, heteroatom-bridged pyrazole and imidazole derivatives and their use
UY33041A (en)	2009-11-27	2011-06-30	Bayer Schering Pharma Aktienegesellschaft	PROCEDURE FOR THE PREPARATION OF {4,6-DIAMINO-2- [1- (2-FLUOROBENCIL) -1H-PIRAZOLO [3,4-B] PIRIDIN-3-IL] PIRIMIDIN-5-IL} CARBAMATO DE METTILO AND ITS PURIFICATION FOR USE AS A PHARMACEUTICAL ACTIVE PRINCIPLE
GB201004311D0 (en)	2010-03-15	2010-04-28	Proximagen Ltd	New enzyme inhibitor compounds
EP3173407A1 (en)	2010-06-30	2017-05-31	Ironwood Pharmaceuticals, Inc.	Sgc stimulators
RU2016101964A (en)	2010-11-09	2018-11-21	Айронвуд Фармасьютикалз, Инк.	SGC STIMULANTS
CN103619845B (en) *	2011-04-21	2016-08-17	拜耳知识产权有限责任公司	Fluoroalkyl-substituted pyrazolopyridines and uses thereof
AU2011376717A1 (en)	2011-09-14	2014-03-20	Proximagen Limited	New enzyme inhibitor compounds
US9139564B2 (en)	2011-12-27	2015-09-22	Ironwood Pharmaceuticals, Inc.	2-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sGC stimulators
WO2013167669A1 (en)	2012-05-10	2013-11-14	Bayer Pharma Aktiengesellschaft	Antibodies capable of binding to the coagulation factor xi and/or its activated form factor xia and uses thereof
WO2015106268A1 (en)	2014-01-13	2015-07-16	Ironwood Pharmaceuticals, Inc.	USE OF sGC STIMULATORS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS
JP6748113B2 (en)	2015-05-06	2020-08-26	バイエル・ファルマ・アクティエンゲゼルシャフト	Use of sGC stimulants, sGC activators alone or in combination with PDE5 inhibitors for treating digital ulcers (DU) associated with systemic sclerosis (SSc)
DK3325013T4 (en)	2015-07-23	2023-10-16	Bayer Pharma AG	STIMULATORS AND/OR ACTIVATORS OF THE SOLUBLE GUANYLATE CYCLASE (SGC) IN COMBINATION WITH AN INHIBITOR OF THE NEUTRAL ENDOPEPTIDASE (NEP INHIBITOR) AND AN ANGIOTENSIN AII ANTAGONIST AND THEIR USE
EA201891416A1 (en)	2015-12-14	2018-12-28	Айронвуд Фармасьютикалз, Инк.	APPLICATION of sGC STIMULATORS FOR THE TREATMENT OF GASTRIC AND INTESTINAL SPINKLIN TREATMENT
WO2017121700A1 (en) *	2016-01-15	2017-07-20	Bayer Pharma Aktiengesellschaft	1,3-disubstituted 1h-pyrazolo[3,4-b]pyridine derivatives and use thereof as stimulators of soluble guanylate cyclase
WO2018069148A1 (en)	2016-10-11	2018-04-19	Bayer Pharma Aktiengesellschaft	Combination containing sgc activators and mineralocorticoid receptor antagonists
ES2985316T3 (en)	2016-10-11	2024-11-05	Bayer Pharma AG	Combination containing the sGC stimulator vericuguat and the mineralocorticoid receptor antagonist finerenone
US20190381039A1 (en)	2016-12-13	2019-12-19	Cyclerion Therapeutics, Inc.	USE OF sGC STIMULATORS FOR THE TREATMENT OF ESOPHAGEAL MOTILITY DISORDERS
JP7090639B2 (en)	2017-04-11	2022-06-24	サンシャイン・レイク・ファーマ・カンパニー・リミテッド	Fluoride-substituted indazole compounds and their use
KR20210008070A (en)	2018-05-15	2021-01-20	바이엘 악티엔게젤샤프트	1,3-thiazol-2-yl substituted benzamide for treatment of diseases associated with nerve fiber sensitization
US12220414B2 (en)	2018-07-11	2025-02-11	Tisento Therapeutics Inc.	Use of sGC stimulators for the treatment of mitochondrial disorders
WO2020164008A1 (en)	2019-02-13	2020-08-20	Bayer Aktiengesellschaft	Process for the preparation of porous microparticles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0615542B2 (en) *	1986-07-22	1994-03-02	吉富製薬株式会社	Pyrazolopyridine compound
US4994482A (en) *	1989-07-31	1991-02-19	Bristol-Myers Squibb Company	Arylpyrazol derivatives as anti-platelet agents, compositions and use
WO1993023036A1 (en) *	1992-05-21	1993-11-25	Yoshitomi Pharmaceutical Industries, Ltd.	Optically active condensed pyrazole compound for use in treating thrombocytopenia and erythropenia
JP2928079B2 (en) *	1994-02-14	1999-07-28	永信薬品工業股▲ふん▼有限公司	1- (Substituted benzyl) -3- (substituted aryl) condensed pyrazoles, their production and use
CN1039536C (en) *	1994-02-28	1998-08-19	永信药品工业股份有限公司	1,3 substituted condensed pyrazole compounds and their application and preparation method

1996
- 1996-11-26 DE DE19649460A patent/DE19649460A1/en not_active Withdrawn
1997
- 1997-11-14 ES ES97951204T patent/ES2214646T3/en not_active Expired - Lifetime
- 1997-11-14 EP EP97951204A patent/EP0944631B1/en not_active Expired - Lifetime
- 1997-11-14 DE DE59711321T patent/DE59711321D1/en not_active Expired - Lifetime
- 1997-11-14 CA CA002272584A patent/CA2272584C/en not_active Expired - Fee Related
- 1997-11-14 NZ NZ335890A patent/NZ335890A/en unknown
- 1997-11-14 AT AT97951204T patent/ATE259812T1/en active
- 1997-11-14 AU AU54823/98A patent/AU729642B2/en not_active Ceased
- 1997-11-14 PT PT97951204T patent/PT944631E/en unknown
- 1997-11-14 DK DK97951204T patent/DK0944631T3/en active
- 1997-11-14 TR TR1999/01172T patent/TR199901172T2/en unknown
- 1997-11-14 ID IDW990388A patent/ID21881A/en unknown
- 1997-11-14 MX MXPA99004826A patent/MXPA99004826A/en not_active IP Right Cessation
- 1997-11-14 CZ CZ991850A patent/CZ185099A3/en unknown
- 1997-11-14 IL IL12999897A patent/IL129998A0/en unknown
- 1997-11-14 HU HU0000562A patent/HUP0000562A3/en unknown
- 1997-11-14 WO PCT/EP1997/006366 patent/WO1998023619A1/en not_active Ceased
- 1997-11-14 JP JP52421898A patent/JP4422800B2/en not_active Expired - Fee Related
- 1997-11-14 EE EEP199900211A patent/EE9900211A/en unknown
- 1997-11-14 BR BR9714363A patent/BR9714363A/en active Search and Examination
- 1997-11-14 CN CN97180065A patent/CN1122032C/en not_active Expired - Fee Related
- 1997-11-14 SK SK676-99A patent/SK67699A3/en unknown
- 1997-11-21 TW TW086117406A patent/TW403746B/en not_active IP Right Cessation
- 1997-11-25 ZA ZA9710573A patent/ZA9710573B/en unknown
- 1997-11-26 AR ARP970105563A patent/AR010310A1/en active IP Right Grant
1999
- 1999-05-19 NO NO992400A patent/NO992400D0/en unknown
2009
- 2009-09-11 JP JP2009210476A patent/JP2010013475A/en not_active Ceased

Also Published As

Publication number	Publication date
CA2272584C (en)	2007-10-16
JP2001505567A (en)	2001-04-24
AU5482398A (en)	1998-06-22
TW403746B (en)	2000-09-01
HK1023119A1 (en)	2000-09-01
JP4422800B2 (en)	2010-02-24
NO992400L (en)	1999-05-19
ID21881A (en)	1999-08-05
AR010310A1 (en)	2000-06-07
WO1998023619A1 (en)	1998-06-04
BR9714363A (en)	2000-03-21
DE59711321D1 (en)	2004-03-25
CZ185099A3 (en)	1999-08-11
SK67699A3 (en)	2000-02-14
AU729642B2 (en)	2001-02-08
PT944631E (en)	2004-06-30
EP0944631B1 (en)	2004-02-18
ZA9710573B (en)	1998-06-10
CN1238773A (en)	1999-12-15
HUP0000562A2 (en)	2000-10-28
DK0944631T3 (en)	2004-06-07
CA2272584A1 (en)	1998-06-04
CN1122032C (en)	2003-09-24
JP2010013475A (en)	2010-01-21
MXPA99004826A (en)	2008-02-19
EP0944631A1 (en)	1999-09-29
TR199901172T2 (en)	1999-08-23
HUP0000562A3 (en)	2001-12-28
NO992400D0 (en)	1999-05-19
ES2214646T3 (en)	2004-09-16
NZ335890A (en)	2001-02-23
ATE259812T1 (en)	2004-03-15
DE19649460A1 (en)	1998-05-28
IL129998A0 (en)	2000-02-29

Publication	Publication Date	Title
EE9900211A (en)	1999-12-15	Substituted pyrazole derivatives
ATE360618T1 (en)	2007-05-15	PYRAZOLE DERIVATIVES
DE69719547D1 (en)	2003-04-10	PARASITICIDAL PYRAZOLE DERIVATIVES
DE69735712D1 (en)	2006-05-24	ARYL-PYRIMIDINE DERIVATIVES
ATE261942T1 (en)	2004-04-15	6-PHENYLPYRIDINE DERIVATIVES
FI971234A7 (en)	1997-05-23	Imidazole derivatives
FI951052A7 (en)	1995-09-09	3-phenylpyrrolidine derivatives
ATE260243T1 (en)	2004-03-15	N-AROYLPHENYLALANINE DERIVATIVES
ATE235220T1 (en)	2003-04-15	RESOCINE DERIVATIVES
FI953827L (en)	1996-02-13	Tricyclic pyrazole derivatives
NO981946D0 (en)	1998-04-29	Imidazoquinazolin derivatives
IS4800A (en)	1998-07-21	New 19-nor-pregnene derivatives
ATE302192T1 (en)	2005-09-15	TRICYCLIC PYROLEN OR PYRAZOLE DERIVATIVES
DE69732576D1 (en)	2005-03-31	TETRAHYDROBENZINDOLON DERIVATIVES
ATE255098T1 (en)	2003-12-15	SUBSTITUTED CHROMEDER DERIVATIVES
ATE440854T1 (en)	2009-09-15	5-DEOXY-CYTIDINE DERIVATIVES
ATE255099T1 (en)	2003-12-15	SUBSTITUTED CHROMEDER DERIVATIVES
PT918756E (en)	2004-06-30	PARASITICID PYRAZOLES
IS5026A (en)	1999-04-15	2-methoxyphenylpiperazine derivatives
ATE239018T1 (en)	2003-05-15	PYRAZOLE DERIVATIVES
ATE292632T1 (en)	2005-04-15	CIS-DISUBSTITUTED AMINOCYCLOALKYL-PYRROLIDINE DERIVATIVES
BR9604847A (en)	1998-06-16	Pyrazole derivatives
BR9607749A (en)	1998-06-23	Pyrazole derivatives
NO993628L (en)	1999-09-22	Pyrazole derivatives
DE69710921D1 (en)	2002-04-11	HETEROCYCLIC SUBSTITUTED PYRROLIDINAMIDE DERIVATIVES